REDMOND, Wash.–(HSMN NewsFeed)–Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., (NYSE: MDT ) announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market the LIFEPAK 15 monitor/defibrillator with…
Devices, Monitoring, FDA
Medtronic, Physio-Control, LIFEPAK 15

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Physio-Control Receives FDA 510(k) Clearance for LIFEPAK 15 Monitor/Defibrillator”
Leave a Comment